A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Other communicable disease surveillance
Antibiotic resistance in AustraliaSince the release of The Commonwealth Government Response to the Report of the Joint Expert Technical Advisory Group on Antibiotic Resistance (JETACAR) in October 2000, the government has continued its work toward the development of a national antibiotic resistance management program.113 Two committees were established to further this aim:
- The Expert Advisory Group for Antimicrobial Resistance (EAGAR), was set up in April 2001 under the auspices of the National Health and Medical Research Council, to provide continuing advice on antibiotic resistance and related matters; and
- The Commonwealth Interdepartmental JETACAR Implementation Group was established in November 2000, to oversee and coordinate the continuing government response to JETACAR, to respond to the policy advice received from EAGAR and to seek funding for implementation purposes.
Activities undertaken by the Commonwealth Interdepartmental JETACAR Implementation Group and its member agencies in 2001 include:
- an informal consultation meeting in March, The Monitoring of the Distribution of Antibiotics for Veterinary and Human Use in Australia; and
- the release in April of the draft report, National surveillance of healthcare associated infection in Australia, for consultation.
- the workshop on Antibiotic Resistance Surveillance(4 May);
- the National Summit on Antibiotic Resistance (30 and 31 May);
- a nationwide consultation toward development of a National Antibiotic Resistance Surveillance System for Antibiotic Resistance Management (July-September); and
- the initiation of the EAGAR website -(This web site was available at www.nhmrc.gov.au/about/committees/expert/eagar/index.htm at the time of publication.)
Through the National Summit on Antibiotic Resistance, representatives from governments, health, agricultural, industry and consumer groups identified priorities for action. In particular, the need for the development of a national system of surveillance for antibiotics was recognised to measure the prevalence of antibiotic resistance. Further needs were also identified including:
- improved education and awareness, leading to more appropriate use of antibiotics;
- clearer research focuses, and better communication and regulation;
- more effective linkages between corporate and peak organisational bodies; and
- reduced incidence of health care-associated infections in Australia.
This article was published in Communicable Diseases Intelligence Volume 27, No 1, March 2003.
Communicable Diseases Surveillance
CDI Vol 27, No 1, March 2003
NNDSS 2001 Annual Report
- Table of contents
- Lists - Tables, Figures, Maps
- Population by statistical division
- 2001: The year in review
- Introduction, Methods, Notes
- Results - Summary, Table 2 and 3
- Results - Table 4a and 4b
- Other surveillance
Communicable Diseases Intelligence